<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02683837</url>
  </required_header>
  <id_info>
    <org_study_id>Pupilloped</org_study_id>
    <nct_id>NCT02683837</nct_id>
  </id_info>
  <brief_title>Pupillometry Guided Remifentanil Administration In Pediatric Anesthesia</brief_title>
  <official_title>A Prospective Randomized Study Evaluating Pupillometry Guided Remifentanil Administration in Pediatric Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective randomized study is to evaluate the impact of peroperative
      pupillometry monitoring on per and post-operative opioid consumption in pediatric anesthesia.
      All patients are anesthetized with sevoflurane and remifentanil. In the intervention group,
      peroperative remifentanil infusion rate is guided by pupillometry. In the other group,
      remifentanil infusion rate is guided according to hemodynamic data.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>peroperative remifentanil consumption</measure>
    <time_frame>duration of surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>during the 24 hour post operative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of morphine side effects</measure>
    <time_frame>during the 24 hour post operative period</time_frame>
    <description>Sedation, nausea, vomiting, pruritus, urinary retention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scoring (verbal numerical scale)</measure>
    <time_frame>during the 24 hour post operative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scoring (questionnaire)</measure>
    <time_frame>one month post-operatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Anesthesia</condition>
  <condition>Pain</condition>
  <condition>Child</condition>
  <arm_group>
    <arm_group_label>Standard practice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Remifentanil infusion guided by usual clinical signs (heart rate, blood pressure).
Pupillometry blindly recorded. Anesthesia maintenance with sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pupillometry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remifentanil infusion guided by changes in pupillary diameter. Anesthesia maintenance with sevoflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <arm_group_label>Standard practice</arm_group_label>
    <arm_group_label>Pupillometry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pupillometry</intervention_name>
    <description>Pupillary diameter measured every 5 minutes</description>
    <arm_group_label>Pupillometry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Administered to maintain a Bispectral Index between 40 and 60</description>
    <arm_group_label>Standard practice</arm_group_label>
    <arm_group_label>Pupillometry</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children scheduled for a surgery lasting more than 90 minutes.

        Exclusion Criteria:

          -  Contraindication to sevoflurane, to remifentanil or to morphine.

          -  Peripheral or central nerve block during and after surgery.

          -  Ophthalmological disease.

          -  Peroperative position with no acess to the head.

          -  Chronic use of medication interfering with pupillary diameter.

          -  Ambulatory surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Walid Habre, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Geneva</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolas Louvet, MD</last_name>
    <phone>+41795532024</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Geneva Children's Hospital</name>
      <address>
        <city>Geneva</city>
        <zip>1206</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Walid Habre, MD, PhD</last_name>
      <phone>+41 22 37 27 504</phone>
    </contact>
    <contact_backup>
      <last_name>Nicolas Louvet, MD</last_name>
      <phone>+41 79 55 32 024</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2016</study_first_submitted>
  <study_first_submitted_qc>February 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2016</study_first_posted>
  <last_update_submitted>October 30, 2016</last_update_submitted>
  <last_update_submitted_qc>October 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Walid HABRE</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Intraoperative Neurophysiological Monitoring</keyword>
  <keyword>Reflex, Pupillary</keyword>
  <keyword>remifentanil</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

